Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehrad Mahmoudian

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Bioinformatics (Oxford, England)|July 16, 2021
Stable Iterative Variable SelectionMehrad Mahmoudian, Mikko S Venäläinen, Riku Klén, et al.
Journal of Hypertension|January 25, 2020
Easy-to-use tool for evaluating the elevated acute kidney injury risk against reduced cardiovascular disease risk during intensive blood pressure controlMikko S Venäläinen, Riku Klén, Mehrad Mahmoudian, et al.
F1000Research|June 29, 2019
A predictive model of overall survival in patients with metastatic castration-resistant prostate cancerMehrad Mahmoudian, Fatemeh Seyednasrollah, Liisa Koivu, et al.
Reproduction (Cambridge, England)|September 16, 2022
Cell type markers indicate distinct contributions of decidual stromal cells and natural killer cells in preeclampsiaKalle T Rytkönen, Nigatu Adossa, Mehrad Mahmoudian, et al.
European Urology|February 13, 2017
How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer?Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al.
European Urology|May 14, 2017
Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40. Clinical Utility of Trial-estimated Prognostic ModelsFatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al.
Scandinavian Journal of Urology|September 26, 2019
Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodologyRiku Klén, Antti P Salminen, Mehrad Mahmoudian, et al.
NAR Genomics and Bioinformatics|July 8, 2021
Differential ATAC-seq and ChIP-seq peak detection using ROTSThomas Faux, Kalle T Rytkönen, Mehrad Mahmoudian, et al.
Reproduction (Cambridge, England)|April 10, 2020
Transcriptomic responses to hypoxia in endometrial and decidual stromal cellsKalle T Rytkönen, Taija Heinosalo, Mehrad Mahmoudian, et al.
Journal of Proteome Research|November 23, 2019
Data-Independent Acquisition Mass Spectrometry in Metaproteomics of Gut Microbiota-Implementation and Computational AnalysisJuhani Aakko, Sami Pietilä, Tomi Suomi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Bioinformatics (Oxford, England)|July 16, 2021
Stable Iterative Variable SelectionMehrad Mahmoudian, Mikko S Venäläinen, Riku Klén, et al.
Journal of Hypertension|January 25, 2020
Easy-to-use tool for evaluating the elevated acute kidney injury risk against reduced cardiovascular disease risk during intensive blood pressure controlMikko S Venäläinen, Riku Klén, Mehrad Mahmoudian, et al.
F1000Research|June 29, 2019
A predictive model of overall survival in patients with metastatic castration-resistant prostate cancerMehrad Mahmoudian, Fatemeh Seyednasrollah, Liisa Koivu, et al.
Reproduction (Cambridge, England)|September 16, 2022
Cell type markers indicate distinct contributions of decidual stromal cells and natural killer cells in preeclampsiaKalle T Rytkönen, Nigatu Adossa, Mehrad Mahmoudian, et al.
European Urology|February 13, 2017
How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer?Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al.
European Urology|May 14, 2017
Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40. Clinical Utility of Trial-estimated Prognostic ModelsFatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al.
Scandinavian Journal of Urology|September 26, 2019
Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodologyRiku Klén, Antti P Salminen, Mehrad Mahmoudian, et al.
NAR Genomics and Bioinformatics|July 8, 2021
Differential ATAC-seq and ChIP-seq peak detection using ROTSThomas Faux, Kalle T Rytkönen, Mehrad Mahmoudian, et al.
Reproduction (Cambridge, England)|April 10, 2020
Transcriptomic responses to hypoxia in endometrial and decidual stromal cellsKalle T Rytkönen, Taija Heinosalo, Mehrad Mahmoudian, et al.
Journal of Proteome Research|November 23, 2019
Data-Independent Acquisition Mass Spectrometry in Metaproteomics of Gut Microbiota-Implementation and Computational AnalysisJuhani Aakko, Sami Pietilä, Tomi Suomi, et al.
Pageof 2